UNSPSC 51384619: Trifezolac

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XJ3W180C22. European Medicines Agency schedules Trifezolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11283MIG. Trifezolac generally arises in the molecular formula C23H18N2O2.

UNSPSC 51384619 Trifezolac, a Commodity code, shows minimal relevant recent activity in state and local procurement. The code nominally refers to a specific pharmaceutical compound, but the three recent state and local opportunities tagged to it involve naloxone and safe drug deactivation systems, direct-to-manufacturer pharmacy prescriptions, and generic multi-source pharmaceuticals and OTC products — none of which align with trifezolac's scope. Issuing bodies include Seminole County, Florida (a county health procurement), the Texas Health and Human Services Commission (a state agency), and the Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple states including Oregon. The mismatch between the code's nominal product and the opportunities posted under it suggests either tagging errors in the source data or that trifezolac procurement does not currently drive state and local activity under this code.

Recent opportunities include Seminole County's competitive IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford; the Texas HHS Commission's Request for Information (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer pharmacy prescription contracting capabilities; and the Minnesota Department of Administration's RFP through MMCAP (S1070000015802, due March 26, 2026) to establish multi-state contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers. Geographic activity spans Florida, Texas, Minnesota, and Oregon, though the code itself does not support a reliable characterization of trifezolac-specific demand.